Factors influencing patient preferences for obesity pharmacotherapy: The triangulation of semi-structured interviews, photovoice study and focus group discussions

2026 | Obesity pillars | Journal Article

Matched peptide: Tirzepatide | Metabolic | Human

Obesity is a complex and chronic disease associated with complications including type 2 diabetes, cardiovascular disease, and malignancy. Although pharmacotherapy has emerged as an effective treatment option, the determinants of patient preferences for specific pharmacological agents remain insufficiently characterized. This was a...

Glucagon-like peptide 1 receptor agonists in substance use disorders: A systematic review of ClinicalTrials.Gov

2026 | Addictive behaviors reports | Journal Article

Matched peptide: Tirzepatide | Metabolic

Substance use disorders (SUDs) are widely prevalent and associated with high morbidity and mortality. Current treatments have limited efficacy and there are no United States Food and Drug Administration (FDA)-approved treatments for several SUDs (such as methamphetamine, cocaine, and cannabis use disorders). Emerging evidence suggests...

Liraglutide prevents lupus-associated diffuse alveolar hemorrhage via inhibiting lymphocyte infiltration and promoting macrophage M2 polarization

2026 | Journal of translational autoimmunity | Journal Article

Matched peptide: Liraglutide | Metabolic | Mouse

This study aimed to explore the prophylactic and therapeutic role of liraglutide for lupus-associated diffuse alveolar hemorrhage (DAH). A lupus-associated DAH model was established in 6-8-week-old female C57BL/6 mice via intraperitoneal injection of 0.5 mL pristane. Mice were randomized to receive daily intraperitoneal...

Therapeutic Peptides in Orthopaedics: Applications, Challenges, and Future Directions

2026 | Journal of the American Academy of Orthopaedic Surgeons. Global research & reviews | Journal Article

Matched peptide: Tesamorelin | Growth Hormone Secretagogue

Therapeutic peptides are emerging as promising adjuncts in the management of orthopaedic injuries, grounded in their ability to modulate molecular signaling networks central to cellular medicine. By acting on key pathways such as PI3K/Akt, mTOR, MAPK, TGF-beta, and AMPK, peptides exert influence over tissue regeneration,...

Analysis of growth hormone releasing hormone and its analogs in urine using nano liquid chromatography coupled with quadrupole/orbitrap mass spectrometry

2026 | Journal of pharmaceutical and biomedical analysis | Journal Article

Matched peptide: Tesamorelin | Growth Hormone Secretagogue

Growth hormone-releasing hormone (GHRH) and its synthetic analogs are considered performance-enhancing substances and are therefore prohibited by the World Anti-Doping Agency (WADA). The analysis of GHRH and its analogs in urine presents significant analytical challenges due to their inherent in vivo instability, rapid renal...

Retatrutide Phase 2b results: hepatic fat fraction and cardiometabolic markers

2024 | Nat Med | Journal Article

Matched peptide: Retatrutide | Metabolic

Stable gastric pentadecapeptide BPC 157 heals rectal lesions in rats

2023 | Biomedicines | Journal Article

Matched peptide: BPC-157 | Healing & Recovery

Tirzepatide for the Treatment of Obesity: Rationale and Design of the SURMOUNT Clinical Development Program

2023 | Obesity | Journal Article

Matched peptide: Tirzepatide | Metabolic

Retatrutide, a GIP, GLP-1 and Glucagon Receptor Agonist, for People with Type 2 Diabetes

2023 | N Engl J Med | Journal Article

Matched peptide: Retatrutide | Metabolic

Triple-hormone-receptor agonist retatrutide for obesity - a Phase 2 trial

2023 | N Engl J Med | Journal Article

Matched peptide: Retatrutide | Metabolic

Tirzepatide for Metabolic Dysfunction-Associated Steatohepatitis

2023 | N Engl J Med | Journal Article

Matched peptide: Tirzepatide | Metabolic

Tirzepatide Once Weekly for the Treatment of Obesity

2022 | N Engl J Med | Journal Article

Matched peptide: Tirzepatide | Metabolic